4.6 Article

The Global Burden of Meningitis in Children: Challenges with Interpreting Global Health Estimates

期刊

MICROORGANISMS
卷 9, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/microorganisms9020377

关键词

meningitis; child mortality; neonatal sepsis; global health; global health estimates; modelling; Streptococcus pneumoniae; Haemophilus influenzae; Neisseria meningitidis

资金

  1. GSK
  2. Pfizer
  3. Sanofi

向作者/读者索取更多资源

The World Health Organization has developed a global roadmap to defeat meningitis by 2030, advocating for and tracking progress. Accurately defining the burden of meningitis globally, based on different health models, is crucial for monitoring progress and aligning estimates with additional data sources such as national surveillance.
The World Health Organization (WHO) has developed a global roadmap to defeat meningitis by 2030. To advocate for and track progress of the roadmap, the burden of meningitis as a syndrome and by pathogen must be accurately defined. Three major global health models estimating meningitis mortality as a syndrome and/or by causative pathogen were identified and compared for the baseline year 2015. Two models, (1) the WHO and the Johns Hopkins Bloomberg School of Public Health's Maternal and Child Epidemiology Estimation (MCEE) group's Child Mortality Estimation (WHO-MCEE) and (2) the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease Study (GBD 2017), identified meningitis, encephalitis and neonatal sepsis, collectively, to be the second and third largest infectious killers of children under five years, respectively. Global meningitis/encephalitis and neonatal sepsis mortality estimates differed more substantially between models than mortality estimates for selected infectious causes of death and all causes of death combined. Estimates at national level and by pathogen also differed markedly between models. Aligning modelled estimates with additional data sources, such as national or sentinel surveillance, could more accurately define the global burden of meningitis and help track progress against the WHO roadmap.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据